Gatlin in fresh drug probe

December 19, 2017


World champion Justin Gatlin is at the centre of another doping controversy after the United States Anti-Doping Agency (USADA) and the Athletics Integrity Unit for the IAAF said they were investigating the American sprinter as well as his coach and an associated agent.

"Investigations from tips and whistleblowers play a critical role in anti-doping efforts," a USADA spokesperson told British newspaper The Telegraph, after undercover reporters were told by Gatlin's coach Dennis Mitchell and Robert Wagner, who has in the past worked as an agent for Gatlin, that they could source performance enhancement drugs (PEDs) after the reporters - posing as connections for an actor working on a film about athletics, asked for their assistance in securing the drugs.

"We are presently coordinating with the Athletics Integrity Unit in order to investigate these claims fully," the spokesperson continued.

The reporters were reportedly also told that Gatlin had used PEDs but the sprinter, through his manager Renaldo Nehemiah, has strongly denied these claims.

Nehemiah told The Telegraph that Wagner had only worked for Gatlin on two or three occasions. Nehemiah also said that Gatlin was not present for any discussions of banned substances by Wagner or Mitchell.

Other Sports Stories